In conclusion, we showed the clinically relevant classification of endometrial carcinoma when the analysis of MMR and p53 protein expression was combined with the assessment of tumor-infiltrating CD8-positive TCs, inspired by the concepts of TCGA. This evidence concerns the gene TP53 and endometrial carcinoma.